Fibronostics Revenue and Competitors
Estimated Revenue & Valuation
- Fibronostics's estimated annual revenue is currently $2.1M per year.
- Fibronostics's estimated revenue per employee is $98,000
Employee Data
- Fibronostics has 21 Employees.
- Fibronostics grew their employee count by 40% last year.
Fibronostics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | COO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Director Customer Operations | Reveal Email/Phone |
4 | Operations Director | Reveal Email/Phone |
5 | Commercial Director | Reveal Email/Phone |
6 | Finance Director | Reveal Email/Phone |
7 | Customer Operations Manager | Reveal Email/Phone |
8 | Area Sales and Business Development Director | Reveal Email/Phone |
9 | General Manager, Americas | Reveal Email/Phone |
10 | Business Development Manager | Reveal Email/Phone |
Fibronostics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.1M | 56 | -8% | N/A | N/A |
#2 | $317.9M | 1588 | 8% | $332.6M | N/A |
#3 | $150.7M | 769 | 13% | N/A | N/A |
#4 | $32.2M | 214 | 0% | N/A | N/A |
#5 | $4.8M | 43 | -14% | N/A | N/A |
#6 | $15.5M | 111 | -12% | $150K | N/A |
#7 | $1.4M | 17 | N/A | N/A | N/A |
#8 | $1.9M | 27 | -7% | $54.7M | N/A |
#9 | $1.6M | 19 | 6% | N/A | N/A |
#10 | $0.3M | 4 | N/A | N/A | N/A |
What Is Fibronostics?
Fibronostics is a healthcare technology company providing algorithm-based solutions in a variety of diagnostic testing areas, focusing on assessing liver disease existence/progression, but also other chronic areas such as coronary heart disease, stroke, diabetes, and obstructive sleep apnea. Fibronostics' LIVERFASt products provide early detection and monitoring for patients with NAFLD & NASH when a diagnosis is often missed due to limited screening with low-sensitivity tools. The current standard for diagnosis is risky and costly with mounting evidence calling for an efficacious and cost-effective non-invasive diagnostic tool. Fibronostics' HealthFACTR tool employes technology to predict risk, providing results for risks of coronary heart disease, stroke, diabetes and fatty liver disease. HealthFACTR enables action-oriented recommendations which allow healthcare professions to determine patients' risk levels and drive better patient care.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$2.1M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Orlando
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 21 | -16% | N/A |
#2 | $5.2M | 21 | -19% | N/A |
#3 | $4M | 21 | N/A | N/A |
#4 | $1.7M | 21 | -32% | N/A |
#5 | $1.7M | 21 | 5% | N/A |